Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Dunger

Showing results (181-190 of 298) with videos related to

Pageof 30
Sort By:
Diabetes|July 29, 2006
Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetesTero Saukkonen, Fariba Shojaee-Moradie, Rachel M Williams, et al.
Frontiers in Endocrinology|March 30, 2018
Serum Phthalate and Triclosan Levels Have Opposing Associations With Risk Factors for Gestational Diabetes MellitusBenjamin G Fisher, Hanne Frederiksen, Anna-Maria Andersson, et al.
Diabetes Care|January 8, 2016
Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical TrialMartin Tauschmann, Janet M Allen, Malgorzata E Wilinska, et al.
The Journal of Clinical Endocrinology and Metabolism|March 18, 2010
Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistanceFiona M Regan, Rachel M Williams, Anna McDonald, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetesTero Saukkonen, Rakesh Amin, Rachel M Williams, et al.
Clinical Endocrinology|June 9, 2007
Insulin resistance after precocious pubarche: relation to PAI-1-675 4G/5G polymorphism, and opposing influences of prenatal and postnatal weight gainAbel López-Bermejo, Paula Casano-Sancho, Clive J Petry, et al.
BMJ Open Diabetes Research & Care|December 3, 2014
Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parentsKatharine D Barnard, Tim Wysocki, Janet M Allen, et al.
BMC Pediatrics|March 29, 2011
Nutritional status and HIV in rural South African childrenElizabeth W Kimani-Murage, Shane A Norris, John M Pettifor, et al.
The Journal of Clinical Endocrinology and Metabolism|January 13, 2004
Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetesHelen L Simpson, Nicola C Jackson, Fariba Shojaee-Moradie, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 14, 2006
Associations between common variation in the aromatase gene promoter region and testosterone concentrations in two young female populationsClive J Petry, Ken K Ong, Katherine F Michelmore, et al.
Pageof 30

Showing results (181-190 of 298) with videos related to

Sort By:
Pageof 30
Diabetes|July 29, 2006
Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetesTero Saukkonen, Fariba Shojaee-Moradie, Rachel M Williams, et al.
Frontiers in Endocrinology|March 30, 2018
Serum Phthalate and Triclosan Levels Have Opposing Associations With Risk Factors for Gestational Diabetes MellitusBenjamin G Fisher, Hanne Frederiksen, Anna-Maria Andersson, et al.
Diabetes Care|January 8, 2016
Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical TrialMartin Tauschmann, Janet M Allen, Malgorzata E Wilinska, et al.
The Journal of Clinical Endocrinology and Metabolism|March 18, 2010
Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistanceFiona M Regan, Rachel M Williams, Anna McDonald, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetesTero Saukkonen, Rakesh Amin, Rachel M Williams, et al.
Clinical Endocrinology|June 9, 2007
Insulin resistance after precocious pubarche: relation to PAI-1-675 4G/5G polymorphism, and opposing influences of prenatal and postnatal weight gainAbel López-Bermejo, Paula Casano-Sancho, Clive J Petry, et al.
BMJ Open Diabetes Research & Care|December 3, 2014
Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parentsKatharine D Barnard, Tim Wysocki, Janet M Allen, et al.
BMC Pediatrics|March 29, 2011
Nutritional status and HIV in rural South African childrenElizabeth W Kimani-Murage, Shane A Norris, John M Pettifor, et al.
The Journal of Clinical Endocrinology and Metabolism|January 13, 2004
Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetesHelen L Simpson, Nicola C Jackson, Fariba Shojaee-Moradie, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 14, 2006
Associations between common variation in the aromatase gene promoter region and testosterone concentrations in two young female populationsClive J Petry, Ken K Ong, Katherine F Michelmore, et al.
Pageof 30